By Josh White
Date: Friday 07 Nov 2025
(Sharecast News) - Tissue Regenix warned on Friday that it urgently needs to raise fresh capital to remain in business, after uncovering a significant creditor backlog and limited cash reserves.
The regenerative medical devices company said it must secure funding by the end of November or it will be unable to...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news